Gracell Biotechnologies Inc. (GRCL): Eigentümerstruktur Nicht notiert
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Gracell Biotechnologies Inc.
Mitarbeiter 314
Handelsplatz NASDAQ
Ticker Symbol GRCL
IPO Datum 2021-01-08
Adresse Building 12, Block B, Suzhou, China, 215123
Webseite https://www.gracellbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Wei Cao BM, Ph.D. | Founder, Chairman & CEO |
| 2 | Dr. Yili Xie M.B.A., Ph.D. | Chief Financial Officer |
| 3 | Dr. Samuel Suhua Zhang M.B.A., Ph.D. | Chief Business Officer |
| 4 | Dr. Wendy Li M.D. | Chief Medical Officer |
| 5 | Ms. Erin Li | Executive Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Temasek Holdings Ltd. | 9,93% | 98,29 Mio. USD |
| 2 | Vivo Capital, LLC | 9,89% | 97,85 Mio. USD |
| 3 | Orbimed Advisors, LLC | 9,64% | 95,41 Mio. USD |
| 4 | Sio Capital Management, LLC | 5,18% | 51,27 Mio. USD |
| 5 | TCG Crossover Management, LLC | 4,68% | 46,28 Mio. USD |
| 6 | Baker Bros Advisors LP | 2,15% | 21,32 Mio. USD |
| 7 | Pentwater Capital Management LP | 1,51% | 14,98 Mio. USD |
| 8 | Pivotal bioVenture Partners Investment Advisor LLC | 1,42% | 14,09 Mio. USD |
| 9 | Adage Capital Partners Gp LLC | 1,40% | 13,84 Mio. USD |
| 10 | Test Hedge Fund Mgmt | 1,33% | 13,12 Mio. USD |
| 11 | Eckert Corp | 1,32% | 13,10 Mio. USD |
| 12 | Schonfeld Strategic Advisors LLC | 0,79% | 7,78 Mio. USD |
| 13 | BlackRock Inc | 0,56% | 5,53 Mio. USD |
| 14 | Qube Research & Technologies | 0,54% | 5,30 Mio. USD |
| 15 | Bank of America Corp | 0,53% | 5,25 Mio. USD |
| 16 | LMR Partners LLP | 0,53% | 5,23 Mio. USD |
| 17 | Sphera Funds Management Ltd. | 0,52% | 5,16 Mio. USD |
| 18 | Mmcap International Inc. Spc | 0,47% | 4,63 Mio. USD |
| 19 | Harvest Management LLC | 0,41% | 4,10 Mio. USD |
| 20 | Hudson Bay Capital Management LP | 0,28% | 2,73 Mio. USD |